Covered recipient · General Payments record
BARBARA V HOLDREN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2023
$590.27
- Reported across 29 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $320.73 | 15 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $80.34 | 3 |
| ABBVIE INC. | $80.01 | 4 |
| PFIZER INC. | $42.30 | 2 |
| Lilly USA, LLC | $38.43 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.72 | 1 |
| Abbott Laboratories | $20.67 | 1 |
| Novo Nordisk AS | $18.84 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $18.42 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $20.67 | 02/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1019041757 | CMS |
| ABBVIE INC. | $25.60 | 02/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005575773 | CMS |
| ABBVIE INC. | $13.53 | 06/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005575777 | CMS |
| ABBVIE INC. | $19.64 | 07/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005575781 | CMS |
| ABBVIE INC. | $21.24 | 07/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005575785 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.72 | 01/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997039385 | CMS |
| GlaxoSmithKline, LLC. | $34.79 | 02/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1004092333 | CMS |
| GlaxoSmithKline, LLC. | $24.70 | 06/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1004092339 | CMS |
| GlaxoSmithKline, LLC. | $20.85 | 08/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1004092809 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $18.42 | 01/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034414483 | CMS |
| Lilly USA, LLC | $15.48 | 03/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032752167 | CMS |
| Lilly USA, LLC | $22.95 | 06/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032456495 | CMS |
| Novo Nordisk Inc | $18.84 | 08/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002845163 | CMS |
| PFIZER INC. | $21.15 | 02/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049560787 | CMS |
| PFIZER INC. | $21.15 | 05/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049232069 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.